Daniel McQuaid
Yale Cancer Center(US)Yale University(US)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Prostate Cancer Treatment and Research, Protein Tyrosine Phosphatases, Advanced Proteomics Techniques and Applications, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study(2017)650 cited
- → Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth(2017)197 cited
- → Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate Cancer(2018)82 cited
- → Global assessment of IRF8 as a novel cancer biomarker(2022)14 cited
- → IRF8 as a Novel Marker to Differentiate Between CD30-Positive Large Cell Lymphomas(2022)7 cited
- → Direct genetic transformation bypasses tumor-associated DNA methylation alterations(2025)3 cited
- → Beta cells are essential drivers of pancreatic ductal adenocarcinoma development(2024)1 cited
- → Figure S1-S5. from Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate Cancer(2023)